Recent

% | $
Quotes you view appear here for quick access.

Silver Wheaton Corp. Message Board

rayank7777777 5 posts  |  Last Activity: Mar 30, 2015 8:20 AM Member since: Jul 30, 2011
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • rayank7777777 by rayank7777777 Mar 30, 2015 8:20 AM Flag

    IPCI NEWS: Intellipharmaceutics Reports Positive Topline Data Results from a Series of Phase I Clinical Trials of its Abuse-Deterrent Re...
    Date : 03/30/2015 @ 8:00AM
    Source : GlobeNewswire Inc.
    Stock : Intellipharmaceutics International Inc. (MM) (IPCI)
    Quote : 2.7168 0.0 (0.00%) @ 7:58AM

    Intellipharmaceutics Reports Positive Topline Data Results from a Series of Phase I Clinical Trials of its Abuse-Deterrent Re...
    Print
    Alert
    Intellipharmaceutics International Inc. (MM) (NASDAQ:IPCI)
    Intraday Stock Chart

    Today : Monday 30 March 2015
    Click Here for more Intellipharmaceutics International Inc. (MM) Charts.

    Intellipharmaceutics International Inc. (Nasdaq:IPCI) (TSX:I) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release oral solid dosage drugs, today provided an update on the progress of the product development programs for both its Rexista™ Oxycodone Abuse Deterrent oxycodone hydrochloride extended release tablets and for its Regabatin™ XR once-daily, non-generic extended release version of pregabalin.

    Rexista™ Oxycodone XR

    Rexista™ Oxycodone XR is a non-generic extended release formulation intended for the management of moderate to severe pain when an around-the-clock analgesic is required. The formulation is intended to present a significant barrier to tampering when subjected to various forms of anticipated physical and chemical manipulation commonly used by abusers. It is also designed to prevent dose dumping when inadvertently co-administered with alcohol. In addition, when crushed or pulverized and hydrated, the proposed extended release formulation is designed to coagulate instantaneously and entrap the drug in a viscous hydrogel, which is intended to prevent syringing, injecting and snorting.

    The Company recently submitted an Investigational New Drug Application ("IND") to the United States Food and Drug Administr

    Sentiment: Buy

  • rayank7777777 by rayank7777777 Mar 20, 2015 8:25 AM Flag

    Book Value Per Share (mrq): 4.47

  • For the company’s offshore drilling segment, revenues from drilling contracts increased by $153.9 million to $499.4 million for the three-month period ended December 31, 2014, compared to $345.5 million for the same period in 2013.
    The tanker segment is driving growth.
    For the tanker segment, net voyage revenues amounted to $23.9 million for the three-month period ended December 31, 2014, compared to $11.9 million for the same period in 2013. The TCE rate for the tanker fleet stood at $26,003 per day per vessel in the three-month period ended December 31, 2014. This improvement is significant compared to the $12,963-per-day-per-vessel TCE rate in the corresponding period of 2013. The PowerShares DB Oil Fund ETF (DBO) tracks the performance of crude oil.

    Looking ahead to 2016, Dryships foresees that the strong tanker market should extend well. Other companies are also seeing a similar outlook for the tanker market.

  • DryShips currently has a Zacks Rank #1 (Strong Buy).

  • rayank7777777 by rayank7777777 Feb 19, 2015 6:51 AM Flag

    New insider filings for ONVO: ORGANOVO HOLDINGS, INC.
    First-Class Insider (Chairman, CEO and President): Murphy Keith
    Sold 28,008 Common Stock (Non-Derivative security at $6.340) on Feb 13, 15. Direct holding 5,961,328 shares/units after transaction. Holdings decreased -0.47%.
    Acquired 28,008 Stock Option (Right to Buy) (Derivative security at conversion or exercise price: $6.340) on Feb 13, 15. Direct holding 28,008 shares/units after transaction. Stock Option (Right to Buy) expires on Feb 13, 25.

SLW
19.82-0.44(-2.17%)May 5 4:02 PMEDT